NEU:ASX
Neuren Pharmaceuticals Ltd
A$13.53
arrow_downward
-0.44%(-0.060) 1D
Jun 4, 4:10:15 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$13.44
High
A$13.75
Low
A$13.32
Mkt. cap
1.71B
Avg. vol.
327.56K
Volume
189.21K
P/E ratio
58.13
52-wk high
A$22.98
52-wk low
A$11.00
EPS
A$0.23
Shares outstanding
126.32M
No. of employees
8
Open
A$13.44
High
A$13.75
Low
A$13.32
Mkt. cap
1.71B
Avg. vol.
327.56K
Volume
189.21K
P/E ratio
58.13
52-wk high
A$22.98
52-wk low
A$11.00
EPS
A$0.23
Shares outstanding
126.32M
No. of employees
8
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to NEU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NEU in the last 3 months.
Highest
Current A$13.53
A$24.00 (+77.38%)
Average
A$23.00 (+69.99%)
Lowest
A$22.00 (+62.60%)
News stories
From sources across the web
Stock Titan
·
14 minutes ago
InMed keeps Nasdaq spot after meeting $1 share-price rule
Quartz
·
6 minutes ago
Applied exec Chris Rogers talks next steps for company after NYSE debut
Seeking Alpha
·
28 minutes ago
3 things to look out for on Friday (SP500:)
CBS News
·
2 hours ago
Dow soars nearly 900 points as Wall Street bets on Iran peace deal
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com
AI content may include mistakes. Learn more